Vishria Bird Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-69,676
Closed -$4.42M 51
2019
Q3
$4.42M Buy
69,676
+4,527
+7% +$296K 5.06% 11
2019
Q2
$4.4M Buy
65,149
+4,745
+8% +$312K 4.39% 11
2019
Q1
$3.93M Sell
60,404
-835
-1% -$55.5K 3.97% 13
2018
Q4
$3.83M Buy
61,239
+200
+0.3% +$14K 4.24% 11
2018
Q3
$4.71M Buy
61,039
+235
+0.4% +$17.7K 4.04% 13
2018
Q2
$4.31M Buy
+60,804
New +$4.29M 3.99% 11

Other funds holding GILD

Vishria Bird Financial Group's GILD Position: Q4 2019 in Review

Vishria Bird Financial Group sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 69,676 shares — an estimated $4.42M sold.

Vishria Bird Financial Group first reported a position in GILD in Q2 2018 and held it in 6 quarters. The position peaked at $4.71M in Q3 2018. 1,556 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Vishria Bird Financial Group reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
  • Vishria Bird Financial Group sold 69,676 Gilead Sciences shares in Q4 2019, an estimated $4.42M.
  • Vishria Bird Financial Group first reported a position in Gilead Sciences in Q2 2018 and held it in 6 quarters.
  • Vishria Bird Financial Group's Gilead Sciences position peaked at $4.71M in Q3 2018.
  • 1,556 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Vishria Bird Financial Group's 13F filing for Q4 2019, filed 9 Jan 2020.